- Home
- VTVT vs CPIX Comparison
VTVT vs CPIX Comparison
Compare VTVT & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTVT
- CPIX
- Stock Information
- Founded
- VTVT 2015
- CPIX 1999
- Country
- VTVT United States
- CPIX United States
- Employees
- VTVT N/A
- CPIX N/A
- Industry
- VTVT Biotechnology: Pharmaceutical Preparations
- CPIX Biotechnology: Pharmaceutical Preparations
- Sector
- VTVT Health Care
- CPIX Health Care
- Exchange
- VTVT Nasdaq
- CPIX Nasdaq
- Market Cap
- VTVT 45.8M
- CPIX 40.1M
- IPO Year
- VTVT 2015
- CPIX 2009
- Fundamental
- Price
- VTVT $14.95
- CPIX $3.44
- Analyst Decision
- VTVT Strong Buy
- CPIX
- Analyst Count
- VTVT 2
- CPIX 0
- Target Price
- VTVT $35.50
- CPIX N/A
- AVG Volume (30 Days)
- VTVT 3.2K
- CPIX 81.2K
- Earning Date
- VTVT 08-07-2025
- CPIX 08-05-2025
- Dividend Yield
- VTVT N/A
- CPIX N/A
- EPS Growth
- VTVT N/A
- CPIX N/A
- EPS
- VTVT N/A
- CPIX N/A
- Revenue
- VTVT $17,000.00
- CPIX $41,083,299.00
- Revenue This Year
- VTVT N/A
- CPIX N/A
- Revenue Next Year
- VTVT N/A
- CPIX N/A
- P/E Ratio
- VTVT N/A
- CPIX N/A
- Revenue Growth
- VTVT N/A
- CPIX 5.82
- 52 Week Low
- VTVT $12.58
- CPIX $1.04
- 52 Week High
- VTVT $26.99
- CPIX $7.25
- Technical
- Relative Strength Index (RSI)
- VTVT 38.23
- CPIX 46.28
- Support Level
- VTVT $15.52
- CPIX $3.25
- Resistance Level
- VTVT $17.46
- CPIX $3.97
- Average True Range (ATR)
- VTVT 0.47
- CPIX 0.36
- MACD
- VTVT -0.15
- CPIX 0.07
- Stochastic Oscillator
- VTVT 6.05
- CPIX 45.36
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.